Company type | Public company |
---|---|
LSE: RENE | |
Industry | Stem cell research & development |
Founded | 1997 |
Headquarters | Surrey, England, UK |
Key people | chairman = Trevor Jones |
Website | reneuron.com |
ReNeuron is a UK-based stem cell research company whose shares are listed on the Alternative Investment Market. Its focus is on the development of stem-cell therapies targeting areas of poorly-met medical need, including peripheral arterial disease, strokes, and retinal diseases.
ReNeuron is testing the effects of neural stem cells on spinal cords for neuroregeneration. [1] They are also testing the use of fetal stem cells on stroke patients. [2]
Company type | Public company |
---|---|
LSE: RENE | |
Industry | Stem cell research & development |
Founded | 1997 |
Headquarters | Surrey, England, UK |
Key people | chairman = Trevor Jones |
Website | reneuron.com |
ReNeuron is a UK-based stem cell research company whose shares are listed on the Alternative Investment Market. Its focus is on the development of stem-cell therapies targeting areas of poorly-met medical need, including peripheral arterial disease, strokes, and retinal diseases.
ReNeuron is testing the effects of neural stem cells on spinal cords for neuroregeneration. [1] They are also testing the use of fetal stem cells on stroke patients. [2]